Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Page Path
HOME > Browse Articles
Search
Jae Kyun Ju 9 Articles
Benign proctology,Complication,Biomarker & risk factor
Recurrent bleeding after posthemorrhoidectomy caused by factor V deficiency: a case report and review of the literature
Jun Seong Chung, Han Deok Kwak, Jae Kyun Ju
Ann Coloproctol. 2022;38(6):449-452.   Published online July 27, 2021
DOI: https://doi.org/10.3393/ac.2021.00185.0026
  • 3,527 View
  • 144 Download
  • 2 Citations
AbstractAbstract PDF
Congenital factor V (FV) deficiency is a rare hemorrhagic disorder that can cause excessive bleeding during and after surgery in the affected patient. This report is the case of a patient who had FV deficiency with recurrent posthemorrhoidectomy bleeding treated with the hemostatic procedure and fresh frozen plasma (FFP) transfusions. A 45-year-old male patient had previously undergone hemorrhoidectomy for multiple hemorrhoids at a local hospital. Hemorrhoidectomy was successful; however, he was transferred to our hospital for evaluation of the origin of the recurrent posthemorrhoidectomy bleeding and underwent a hemostatic procedure. This bleeding was treated with coagulation using electrocautery, multiple sutures, and FFP transfusion (1,600 mL/day) for 7 consecutive days. The patient’s plasma FV activity was 23%. Early detection of clotting factor deficiency in patients with hemorrhagic events after surgical treatments may prevent unnecessary procedures such as reoperations and minimize the cost of replacement therapy such as large-volume FFP transfusion.

Citations

Citations to this article as recorded by  
  • Rare Inherited Coagulation Deficiencies: A Single-Center Study
    Özlem Terzi, Sadik Sami Hatipoğlu
    Journal of Pediatric Hematology/Oncology.2024;[Epub]     CrossRef
  • Plasma/tranexamic-acid/vitamin-k

    Reactions Weekly.2023; 1954(1): 383.     CrossRef
Malignant disease, Functional outcomes,Colorectal cancer
The Relationship Between High-Output Stomas, Postoperative Ileus, and Readmission After Rectal Cancer Surgery With Diverting Ileostomy
Naa Lee, Soo Young Lee, Chang Hyun Kim, Han Deok Kwak, Jae Kyun Ju, Hyeong Rok Kim
Ann Coloproctol. 2021;37(1):44-50.   Published online September 18, 2020
DOI: https://doi.org/10.3393/ac.2020.08.03
  • 3,822 View
  • 166 Download
  • 9 Web of Science
  • 8 Citations
AbstractAbstract PDF
Purpose
This study aimed to evaluate the relationship between high-output stomas (HOSs), postoperative ileus (POI), and readmission after rectal cancer surgery with diverting ileostomy.
Methods
We included 302 patients with rectal cancer who underwent restorative resection with diverting ileostomy between January 2011 and December 2015. HOSs were defined as stomas with ≥ 2,000 mL/day output. We analyzed predictive factors for readmission of these patients.
Results
Forty-eight patients (15.9%) had HOSs during the hospital stay, and 41 patients (13.6%) experienced POI. HOSs were strongly associated with POI (45.8% vs. 7.5%, P < 0.001). The all-cause readmission rate was 16.9%, with 19 (6.3%) and 20 (6.6%) experiencing ileus and acute kidney injury, respectively. HOSs (27.1% vs. 15.0%, P = 0.040) and POI (34.1% vs. 14.2%, P = 0.002) were associated with all-cause readmission, and POI was associated with readmission with ileus (17.1% vs. 4.6%, P = 0.007). POI was an independent risk factor for all-cause readmission (adjusted odds ratio [OR], 2.640; 95% confidence interval [CI], 1.162 to 6.001; P = 0.020) and readmission with ileus (adjusted OR = 3.869; 95% CI 1.387 to 10.792; P = 0.010).
Conclusion
POI was associated with readmission, particularly for subsequent ileus, in patients with diverting ileostomy. We should make efforts to reduce POI, such as strong control of HOSs, to prevent readmission.

Citations

Citations to this article as recorded by  
  • High output stoma after surgery for rectal cancer - a risk factor for low anterior resection syndrome?
    Xuena Zhang, Qingyu Meng, Jianna Du, Zhongtao Tian, Yinju Li, Bin Yu, Wenbo Niu
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Maximizing Readmission Reduction in Colon Cancer Patients
    Mario Schootman, Chenghui Li, Jun Ying, Sonia T. Orcutt, Jonathan Laryea
    Journal of Surgical Research.2024; 295: 587.     CrossRef
  • Analysis of decision-making factors for defunctioning ileostomy after rectal cancer surgery and their impact on perioperative recovery: a retrospective study of 1082 patients
    Xiaojiang Yi, Huaguo Yang, Hongming Li, Xiaochuang Feng, Weilin Liao, Jiaxin Lin, Zhifeng Chen, Dechang Diao, Manzhao Ouyang
    Surgical Endoscopy.2024; 38(11): 6782.     CrossRef
  • Effect of intracorporeal anastomosis on postoperative ileus after laparoscopic right colectomy
    Sangwoo Kim, Sung Uk Bae, Woon Kyung Jeong, Seong Kyu Baek, Young-Gil Son
    Annals of Surgical Treatment and Research.2023; 104(3): 156.     CrossRef
  • The Latest Results and Future Directions of Research for Enhanced Recovery after Surgery in the Field of Colorectal Surgery
    Min Ki Kim
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Overall readmissions and readmissions related to dehydration after creation of an ileostomy: a systematic review and meta-analysis
    I. Vogel, M. Shinkwin, S. L. van der Storm, J. Torkington, J. A.Cornish, P. J. Tanis, R. Hompes, W. A. Bemelman
    Techniques in Coloproctology.2022; 26(5): 333.     CrossRef
  • Postoperative paralytic ileus following debulking surgery in ovarian cancer patients
    Eva K. Egger, Freya Merker, Damian J. Ralser, Milka Marinova, Tim O. Vilz, Hanno Matthaei, Tobias Hilbert, Alexander Mustea
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Obstructive and secretory complications of diverting ileostomy
    Shingo Tsujinaka, Hideyuki Suzuki, Tomoya Miura, Yoshihiro Sato, Chikashi Shibata
    World Journal of Gastroenterology.2022; 28(47): 6732.     CrossRef
Malignant disease, Rectal cancer
Is Whole-Mount Section in Rectal Cancer Effective for Measuring Lateral Margin?
Jun Seong Chung, Han Deok Kwak, Jae Kyun Ju
Ann Coloproctol. 2020;36(3):131-132.   Published online June 30, 2020
DOI: https://doi.org/10.3393/ac.2020.06.12
  • 2,936 View
  • 69 Download
  • 3 Web of Science
  • 4 Citations
PDF

Citations

Citations to this article as recorded by  
  • A comparison of whole-mount and conventional sections for pathological mesorectal extension and circumferential resection margin assessment after total mesorectal excision
    Francisco Giner, Matteo Frasson, Hanna Cholewa, Jorge Sancho-Muriel, Enrique García-Gómez, Josselyn A. Hernández, Blas Flor-Lorente, Eduardo García-Granero
    Cirugía Española (English Edition).2024; 102(8): 417.     CrossRef
  • A comparison of whole-mount and conventional sections for pathological mesorectal extension and circumferential resection margin assessment after total mesorectal excision
    Francisco Giner, Matteo Frasson, Hanna Cholewa, Jorge Sancho-Muriel, Enrique García-Gómez, Josselyn A. Hernández, Blas Flor-Lorente, Eduardo García-Granero
    Cirugía Española.2024; 102(8): 417.     CrossRef
  • MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall Survival
    Hannah M. Thompson, David D. B. Bates, Jennifer Golia Pernicka, Sun Jin Park, Mahra Nourbakhsh, James L. Fuqua, Megan Fiasconaro, Jessica A. Lavery, Iris H. Wei, Emmanouil P. Pappou, J. Joshua Smith, Garrett M. Nash, Martin R. Weiser, Philip B. Paty, Juli
    Annals of Surgical Oncology.2023; 30(7): 3957.     CrossRef
  • Large-Section Histopathology Can Better Indicate the Immune Microenvironment and Predict the Prognosis of Pancreatic Ductal Adenocarcinoma Than Small-Section Histopathology
    Guiling Ding, Meng Guo, Yelin Yang, Chen Sun, Shengyong Wu, Xingchen Liu, Jin Wang, Hui Jiang, Yanfang Liu, Jianming Zheng
    Frontiers in Oncology.2021;[Epub]     CrossRef
Malignant disease
Thirty-Day Readmission After Elective Colorectal Surgery for Colon Cancer: A Single-Center Cohort Study
Jun Seong Chung, Han Deok Kwak, Jae Kyun Ju
Ann Coloproctol. 2020;36(3):186-191.   Published online January 31, 2020
DOI: https://doi.org/10.3393/ac.2019.11.04
  • 3,934 View
  • 113 Download
  • 9 Web of Science
  • 9 Citations
AbstractAbstract PDF
Purpose
There is a concern that enhanced recovery after surgery may affect other proposed quality measures, including the rate of readmission due to early discharge. We examine the 30-day readmission rate, risk factors associated with readmission after elective colorectal surgery for colon cancer, causes of readmission, disease-free survival (DFS), and overall survival (OS) in a single institution.
Methods
We retrospectively investigated 292 patients who underwent elective colorectal surgery for colon cancer between 2010 and 2015. Baseline data including age, sex, body mass index, American Society of Anesthesiologists physical status classification, preoperative comorbidities, previous operation history, TNM stage, surgical approach, operation time, gas passage time, and length of hospital stay were obtained. Univariate and multivariate logistic regression analyses were performed to identify risk factors associated with 30-day readmission.
Results
A total of 229 patients who underwent elective colorectal surgery were enrolled. Twenty-four patients were readmitted 30 days after discharge. The most common readmission diagnoses were wound bleeding or surgical site infection. Multivariate analysis indicated that patients who had preoperative hepatic disease were at the highest risk of readmission (odds ratio [OR], 8.98; 95% confidence interval [CI], 7.35–10.61). Survival outcomes were significantly better in the nonreadmitted group (OS, P=0.00; DFS, P=0.04).
Conclusion
This study identified that preoperative comorbidities including hepatic and pulmonary diseases were associated with higher readmission rates after elective colorectal surgery. Moreover, the most common cause of readmission in patients who underwent elective colorectal surgery was wound bleeding or surgical site infection.

Citations

Citations to this article as recorded by  
  • Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South Korea
    Sanghyun An, Sung Eun Hong, Moo Hyun Kim, Ik Yong Kim
    Frontiers in Surgery.2025;[Epub]     CrossRef
  • Readmission rates following major colorectal surgery
    Aoife Shorten, Matthew G. Davey, William P. Joyce
    The Surgeon.2024; 22(2): 116.     CrossRef
  • Ambulatory Robotic Colectomy: Factors Affecting and Affected by Postoperative Opioid Use
    Michael M. Vu, Jace J. Franko, Anna Buzadzhi, Beau Prey, Maksim Rusev, Marta Lavery, Laila Rashidi
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2024; 34(2): 163.     CrossRef
  • Meta-analysis of postoperative incision infection risk factors in colorectal cancer surgery
    Li Jia, Huacai Zhao, Jia Liu
    Frontiers in Surgery.2024;[Epub]     CrossRef
  • The 30-day readmission rate of patients with an overlap of probable sarcopenia and malnutrition undergoing major oncological surgery
    Hadassa Hillary Novaes Pereira Rodrigues, Kathyelli Thaynara Pimenta de Araujo, José Eduardo de Aguilar-Nascimento, Diana Borges Dock-Nascimento
    einstein (São Paulo).2024;[Epub]     CrossRef
  • Risk factors for early readmission to hospital in patients with malignancy-related ascites: a retrospective cohort study
    Zhenhua Tian, Zhilong Huang, Yaqi Guo, Xiaolin Zhao, Luna Liu, Chunxiao Yu, Qingbo Guan
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • A National Cancer Database analysis of the predictors of unplanned 30-day readmission after proctectomy for rectal adenocarcinoma: The CCF RETURN-30 Score
    Sameh Hany Emile, Nir Horesh, Michael R. Freund, Zoe Garoufalia, Rachel Gefen, Emanuela Silva-Alvarenga, Steven D. Wexner
    Surgery.2023; 173(2): 342.     CrossRef
  • Data analytics and artificial intelligence in predicting length of stay, readmission, and mortality: a population-based study of surgical management of colorectal cancer
    Shamsul Masum, Adrian Hopgood, Samuel Stefan, Karen Flashman, Jim Khan
    Discover Oncology.2022;[Epub]     CrossRef
  • The 30-day hospital readmission and mortality after surgery in colorectal cancer patients
    Mesnad S. Alyabsi, Anwar H. Alqarni, Latifah M. Almutairi, Mohammed A. Algarni, Kanan M. Alshammari, Adel Almutairi, Nahar A. Alselaim
    BMC Gastroenterology.2022;[Epub]     CrossRef
Malignant disease, Rectal cancer
Laparoscopic Resection of a Huge Retrorectal Tumor
Han Deok Kwak, Jae Kyun Ju
Ann Coloproctol. 2020;36(1):54-57.   Published online February 29, 2020
DOI: https://doi.org/10.3393/ac.2018.07.31.1
  • 3,524 View
  • 103 Download
  • 4 Web of Science
  • 5 Citations
AbstractAbstract PDF
Retrorectal space tumors are rare, and so are frequently unrecognized, misdiagnosed, and mistreated. A 57-year-old man visited the outpatient clinic with the chief complaints of thin stool and lower pelvic heaviness. A smooth, round huge palpable mass on the right posterolateral rectal wall was detected and pelvic computed tomography showed a 7.8-cm cystic lesion in the right retrorectal space. Laparoscopic procedures were initiated with perirectal dissection for rectal mobilization. After fixation of the peritoneum and tying the rectum for intracorporeal traction, the rectum was mobilized to identify the cyst. The cyst was removed using an endo-bag, with completion of cyst dissection. The final pathologic diagnosis was a tailgut cyst, or retrorectal cystic hamartoma without evidence of malignancy. The patient was discharged without any complications. The patient had no dyschezia or problems with bowel function. Laparoscopic resection is a safe and feasible method for surgical treatment, even for bulky retrorectal tumors, with an early recovery period.

Citations

Citations to this article as recorded by  
  • Tailgut Cyst—Gynecologist’s Pitfall: Literature Review and Case Report
    Andrei Mihai Malutan, Viorela-Elena Suciu, Florin Laurentiu Ignat, Doru Diculescu, Razvan Ciortea, Emil-Claudiu Boțan, Carmen Elena Bucuri, Maria Patricia Roman, Ionel Nati, Cristina Ormindean, Dan Mihu
    Diagnostics.2025; 15(1): 108.     CrossRef
  • Surgical outcomes after reoperation for patients with recurrent presacral tumors: a retrospective study
    Rui Li, Zhiyuan Yu, Jiahu Ye, Xin Liu, Peiyu Li, Xudong Zhao
    World Journal of Surgical Oncology.2024;[Epub]     CrossRef
  • Total Laparoscopic Excision of a Large Tailgut Cyst
    Ajay Nimbalkar, Anand Zingade, Balaji Dhaigude
    Cureus.2024;[Epub]     CrossRef
  • Epidemiology, diagnostic approach and therapeutic management of tailgut cysts: A systematic review
    Aikaterini Mastoraki, Ilias Giannakodimos, Karmia Panagiotou, Maximos Frountzas, Dimosthenis Chrysikos, Stylianos Kykalos, Georgios E. Theodoropoulos, Dimitrios Schizas
    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • Robotic approach to large tailgut cyst with malignant transformation: A case report
    Alessandra Marano, Maria Carmela Giuffrida, Chiara Peluso, Valentina Testa, Paolo Bosio, Felice Borghi
    International Journal of Surgery Case Reports.2020; 77: S57.     CrossRef
Immunological Differences Between Right-Sided and Left-Sided Colorectal Cancers: A Comparison of Embryologic Midgut and Hindgut
Han Deok Kwak, Jae Kyun Ju
Ann Coloproctol. 2019;35(6):342-346.   Published online December 31, 2019
DOI: https://doi.org/10.3393/ac.2019.03.17.1
  • 3,786 View
  • 96 Download
  • 8 Web of Science
  • 8 Citations
AbstractAbstract PDF
Purpose
There are known differences in embryology, clinical symptoms, incidences, molecular pathways involved, and oncologic outcomes of right-sided and left-sided colorectal cancers. However, immunologic study has only been characterized for healthy adults. The present study was designed to identify differences in immune cell populations in patients with right-sided and left-sided colorectal cancers.
Methods
A total of 35 patients who underwent colorectal resection for cancer between November 2016 and August 2017 at a tertiary teaching hospital were enrolled in this study. Patients were excluded if they had a disease affecting their immune system. Populations of immune cells, including mucosal-associated invariant T (MAIT), gamma delta T, invariant natural killer T, T, natural killer, and B cells, were measured in the peripheral blood and cancer tissues using flow cytometry, and then assessed based on the origin of the colorectal cancer.
Results
Fifteen had right-side and 20 had left-side colorectal cancer. There were no significant differences between the 2 cohorts for patient characteristics including pathologic stage. Peripheral blood from patients with right-side colon cancers contained fewer MAIT (0.87% right-side vs. 1.74% left-side, P = 0.028) and gamma delta T cells (1.10% right-side vs. 3.05% left-side, P = 0.002). Although the group with right-side colorectal cancer had more MAIT cells in cancer tissues (1.71% vs. 1.00%), this difference was not statistically significant.
Conclusion
There is a difference in population sizes of immune cells in blood between patients with right-sided and leftsided colon cancers. The immune cell composition was determined to be distinct based on embryologic origin.

Citations

Citations to this article as recorded by  
  • Survival of Patients with Right-Sided and Left-Sided Colon Cancer: Insights from an Iranian Medical Center
    Alimohammad Bananzadeh, Sara Shojaei-Zarghani, Amir Reza Bahadori, Ali Reza Safarpour
    Shiraz E-Medical Journal.2024;[Epub]     CrossRef
  • Advancements in immunotherapy for colorectal cancer treatment: a comprehensive review of strategies, challenges, and future prospective
    Vaishak Kaviyarasan, Alakesh Das, Dikshita Deka, Biki Saha, Antara Banerjee, Neeta Raj Sharma, Asim K. Duttaroy, Surajit Pathak
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival
    Ramón Cantero-Cid, Karla Marina Montalbán-Hernández, Jenny Guevara, Alejandro Pascual-Iglesias, Elisa Pulido, José Carlos Casalvilla, Cristóbal Marcano, Cristina Barragán Serrano, Jaime Valentín, Gloria Cristina Bonel-Pérez, José Avendaño-Ortiz, Verónica
    World Journal of Gastrointestinal Oncology.2022; 14(1): 295.     CrossRef
  • Epidemiology, risk factors, and prevention of colorectal cancer
    Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim
    Journal of the Korean Medical Association.2022; 65(9): 549.     CrossRef
  • Epidemiology, Risk Factors, and Prevention of Colorectal Cancer-An English Version
    Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim
    Journal of the Anus, Rectum and Colon.2022; 6(4): 231.     CrossRef
  • Variants of creating heterotopic and orthotopic PDX models of human colorectal cancer
    A. A. Kiblitskaya, A. Y. Maksimov, A. S. Goncharova, Ye. M. Nepomnyashchaya, Ye. Y. Zlatnik, G. Y. Yegorov, Ye. A. Lukbanova, Ye. V. Zaikina, A. V. Volkova
    Bulletin of Siberian Medicine.2022; 21(3): 50.     CrossRef
  • Genotypic and Phenotypic Characteristics of Hereditary Colorectal Cancer
    Jin Cheon Kim, Walter F. Bodmer
    Annals of Coloproctology.2021; 37(6): 368.     CrossRef
  • Laterality: Immunological Differences Between Right-Sided and Left-Sided Colon Cancer
    Seong Kyu Baek
    Annals of Coloproctology.2019; 35(6): 291.     CrossRef
Clinical Outcomes of Patients With Locally Advanced Rectal Cancer With Persistent Circumferential Resection Margin Invasion After Preoperative Chemoradiotherapy
Chang Hyun Kim, Seung-Seop Yeom, Hand-Duk Kwak, Soo Young Lee, Jae Kyun Ju, Young Jin Kim, Hyeong Rok Kim
Ann Coloproctol. 2019;35(2):72-82.   Published online April 30, 2019
DOI: https://doi.org/10.3393/ac.2019.04.22
  • 4,746 View
  • 114 Download
  • 14 Web of Science
  • 14 Citations
AbstractAbstract PDF
Purpose
Treatment after failure of circumferential resection margin (CRM) conversion after preoperative chemoradiotherapy (pCRT) for locally advanced rectal cancer (LARC) has not been evaluated well. We conducted a single‐center, retrospective analysis to fill this information gap.
Methods
From 2008 to 2016, we included 112 patients who had predictive CRM involvement on baseline magnetic resonance imaging (MRI) and who underwent surgery following pCRT for LARC. Baseline and posttreatment radiologic and clinical factors were analyzed.
Results
Of 493 patients with LARC, 112 had CRM involvement by baseline MRI (mrCRM). In 40 patients (35.7%), mrCRM involvement was converted as negative posttreatment CRM (ymrCRM−). Multivariate analysis showed the risk factors for persistent CRM involvement (ymrCRM+) after pCRT were extramural venous invasion (mrEMVI+) (P = 0.030) and lower tumor location (P = 0.007). In addition, persistent CRM involvement after pCRT was an independent risk factor for predicting pathologic CRM involvement. The Cox proportional hazard model showed baseline positive mrEMVI remained significant for disease-free survival (DFS) (P < 0.001). On posttreatment MRI, abdominoperineal resection (P = 0.031), intersphincteric resection (P = 0.006), and persistent CRM involvement (P = 0.001) remained significant for local recurrence-free survival. With regard to DFS, persistent CRM involvement (P = 0.048) and positive EMVI on posttreatment MRI (ymrEMVI) (P = 0.014) were significant. In the patient subgroup with persistent CRM involvement, 5-year DFS in patients with mrEMVI and ymrEMVI was 29.8% and 21.2%, respectively.
Conclusion
Patients who fail to convert to negative CRM have extremely poor oncologic outcomes. Lower tumor height and negative mrEMVI status were good responders to ymrCRM conversion. Our results suggest that these patients require a more intensive treatment modality.

Citations

Citations to this article as recorded by  
  • Post‐diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis
    Nerea Becerra‐Tomás, Georgios Markozannes, Margarita Cariolou, Katia Balducci, Rita Vieira, Sonia Kiss, Dagfinn Aune, Darren C. Greenwood, Laure Dossus, Ellen Copson, Andrew G. Renehan, Martijn Bours, Wendy Demark‐Wahnefried, Melissa M. Hudson, Anne M. Ma
    International Journal of Cancer.2024; 155(3): 400.     CrossRef
  • A Review of Neoadjuvant Therapy and the Watch-and-Wait Protocol in Rectal Cancer: Current Evidence and Future Directions
    Iulian M Slavu, Octavian Munteanu, Florin Filipoiu, Raluca Tulin, Anca Monica Macovei Oprescu , Ileana Dima, Iulian A Dogaru, Adrian Tulin
    Cureus.2024;[Epub]     CrossRef
  • A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma
    Shuiwang Qing, Lei Gu, Tingting Du, Xiaolan Yin, Ke-jia Zhang, Huo-jun Zhang
    Technology in Cancer Research & Treatment.2023;[Epub]     CrossRef
  • Oncologic Outcomes Associated With MRI-detected Extramural Venous Invasion (mrEMVI) in Rectal Cancer
    François Rouleau Fournier, Mohammad Ali K. Motamedi, Carl J. Brown, Terry Phang, Manoj J. Raval, Cameron J. Hague, Ahmer A. Karimuddin
    Annals of Surgery.2022; 275(2): 303.     CrossRef
  • Watch and wait strategies for rectal cancer: A systematic review
    In Ja Park
    Precision and Future Medicine.2022; 6(2): 91.     CrossRef
  • Are oncological long-term outcomes equal after laproscopic completed and converted laparoscopic converted rectal resection for cancer?
    M. Finochi, B. Menahem, G. Lebreton, J. Lubrano, Y. Eid, A. Alves
    Techniques in Coloproctology.2021; 25(1): 91.     CrossRef
  • Sphincter‐saving surgery for ultra‐low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long‐term follow‐up?
    Philippe Rouanet, Michel Rivoire, Sophie Gourgou, Bernard Lelong, Eric Rullier, Merhdad Jafari, Laurent Mineur, Marc Pocard, Jean Luc Faucheron, François Dravet, Denis Pezet, Jean Michel Fabre, Laurent Bresler, Jacques Balosso, Christophe Taoum, Claire Le
    Journal of Surgical Oncology.2021; 123(1): 299.     CrossRef
  • The prognostic value of MRI-detected extramural vascular invasion (mrEMVI) for rectal cancer patients treated with neoadjuvant therapy: a meta-analysis
    Silin Chen, Ning Li, Yuan Tang, Jinming Shi, Ying Zhao, Huiying Ma, Shulian Wang, Ye-xiong Li, Jing Jin
    European Radiology.2021; 31(12): 8827.     CrossRef
  • Predictors of Positive Circumferential Resection Margin in Rectal Cancer: A Current Audit of the National Cancer Database
    Hillary L. Simon, Thais Reif de Paula, Magda M. Profeta da Luz, Ravi P. Kiran, Deborah S. Keller
    Diseases of the Colon & Rectum.2021; 64(9): 1096.     CrossRef
  • MRI-detected extramural venous invasion of rectal cancer: Multimodality performance and implications at baseline imaging and after neoadjuvant therapy
    Akitoshi Inoue, Shannon P. Sheedy, Jay P. Heiken, Payam Mohammadinejad, Rondell P. Graham, Hee Eun Lee, Scott R. Kelley, Stephanie L. Hansel, David H. Bruining, Jeff L. Fidler, Joel G. Fletcher
    Insights into Imaging.2021;[Epub]     CrossRef
  • Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes
    Guglielmo Niccolò Piozzi, Seon Hahn Kim
    Annals of Coloproctology.2021; 37(6): 351.     CrossRef
  • Surgical Treatment of Low-Lying Rectal Cancer: Updates
    Cristopher Varela, Nam Kyu Kim
    Annals of Coloproctology.2021; 37(6): 395.     CrossRef
  • Functional outcomes after sphincter-preserving surgeries for low-lying rectal cancer: A review
    Eun Jung Park, Seung Hyuk Baik
    Precision and Future Medicine.2021; 5(4): 164.     CrossRef
  • Reconsideration of the Safety of Laparoscopic Rectal Surgery for Cancer
    Gyung Mo Son, Bong-Hyeon Kye, Min Ki Kim, Jun-Gi Kim
    Annals of Coloproctology.2019; 35(5): 229.     CrossRef
Clinical Significance of Serial Serum Carcinoembryonic Antigen Values for Treating Rectal Cancer with Preoperative Chemoradiotherapy
Young Jae Ryu, Chang Hyun Kim, Hun Jin Kim, Hyo Kang, Sang Woo Lim, Jung Wook Huh, Jae Kyun Ju, Young Jin Kim, Hyeong Rok Kim
J Korean Soc Coloproctol. 2012;28(4):205-212.   Published online August 31, 2012
DOI: https://doi.org/10.3393/jksc.2012.28.4.205
  • 3,566 View
  • 43 Download
  • 6 Citations
AbstractAbstract PDF
Purpose

Preoperative chemoradiotherapy is now widely accepted to treat rectal cancer; however, the prognosis for rectal cancer patients during and after chemoradiotherapy must be determined. The aim of this study was to evaluate the serial serum carcinoembryonic antigen (s-CEA) samples in patients with rectal cancer who underwent radical surgery after concurrent chemoradiotherapy (CRT).

Methods

This study evaluated 236 patients with rectal cancer who received preoperative CRT followed by curative surgery between June 2005 and June 2010. We measured the patient's s-CEA levels pre-CRT, post-CRT and post-surgery. Patients were classified into four groups according to their s-CEA concentrations (group 1, high, high, high; group 2, high, high, normal; group 3, high, normal, normal; group 4, normal, normal, normal). We analyzed the clinicopathologic factors and the outcomes among these groups.

Results

Of the 236 patients, 12 were in group 1, 31 were in group 2, 67 were in group 3, and 126 were in group 4. The 3-year disease-free survival rate in group 1 was poorer than those in group 3 (P = 0.007) and group 4 (P < 0.001). In a univariate analysis, type of surgery, clinical N stage, pathologic T or N stage, lymphovascular invasion, perineural invasion, and CEA group were prognostic factors. A multivariate analysis revealed that type of surgery, pathologic T stage, and lymphovascular invasion were independent prognostic factors; however, no statistical significance was associated with the CEA group.

Conclusion

High pre-CRT, post-CRT, and post-surgery s-CEA levels in patients with rectal cancer were associated with high rates of systemic recurrence and poor survival. Therefore, patients with sustained high s-CEA levels during CRT require careful monitoring after surgery.

Citations

Citations to this article as recorded by  
  • Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative
    Zerong Cai, Jian Xiao, Xiaosheng He, Jia Ke, Yifeng Zou, Yufeng Chen, Xianrui Wu, Xiaoling Li, Lei Wang, Jianping Wang, Ping Lan, Xiaojian Wu
    Cancer Biomarkers.2017; 19(2): 161.     CrossRef
  • Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemor
    SooYoon Sung, Seok Hyun Son, Chul Seung Kay, Yoon Suk Lee
    Medicine.2016; 95(10): e2965.     CrossRef
  • New clinical advances in immunotherapy for the treatment of solid tumours
    Valentina A. Zavala, Alexis M. Kalergis
    Immunology.2015; 145(2): 182.     CrossRef
  • Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
    Chiara Molinari, Federica Matteucci, Paola Caroli, Alessandro Passardi
    Clinical Colorectal Cancer.2015; 14(4): 227.     CrossRef
  • Prognostic factors associated with locally recurrent rectal cancer following primary surgery (Review)
    YANTAO CAI, ZHENYANG LI, XIAODONG GU, YANTIAN FANG, JIANBIN XIANG, ZONGYOU CHEN
    Oncology Letters.2014; 7(1): 10.     CrossRef
  • Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen
    Jung Wook Huh, Chang Hyun Kim, Sang Woo Lim, Hyeong Rok Kim, Young Jin Kim
    Journal of Cancer Research and Clinical Oncology.2013; 139(9): 1449.     CrossRef
The Influence of Nutritional Assessment on the Outcome of Ostomy Takedown
Min Sang Kim, Ho Kun Kim, Dong Yi Kim, Jae Kyun Ju
J Korean Soc Coloproctol. 2012;28(3):145-151.   Published online June 30, 2012
DOI: https://doi.org/10.3393/jksc.2012.28.3.145
  • 3,888 View
  • 31 Download
  • 8 Citations
AbstractAbstract PDF
Purpose

Ostomy takedown is often considered a simple procedure without intention; however, it is associated with significant morbidity. This study is designed to evaluate factors predicting postoperative complications in the ostomy takedown in view of metabolism and nutrition.

Methods

A retrospective, institutional review-board-approved study was performed to identify all patients undergoing takedown of an ostomy from 2004 to 2010.

Results

Of all patients (150), 48 patients (32%; male, 31; female, 17) had complications. Takedown of an end-type ostomy showed a high complication rate; complications occurred in 55.9% of end-type ostomies and 15.7% of loop ostomies (P < 0.001). Severe adhesion was also related to a high rate of overall complication (41.3%) (P = 0.024). In preoperative work-up, ostomy type was not significantly associated with malnutrition status. However, postoperatively severe malnutrition level (albumin <2.8 mg/dL) was statistically significant in increasing the risk of complications (72.7%, P = 0.015). In particular, a significant postoperative decrease in albumin (>1.3 mg/dL) was associated with postoperative complications, particularly surgical site infection (SSI). Marked weight loss such as body mass index downgrading may be associated with the development of complications.

Conclusion

A temporary ostomy may not essentially result in severe malnutrition. However, a postoperative significant decrease in the albumin concentration is an independent risk factor for the development of SSI and complications.

Citations

Citations to this article as recorded by  
  • Investigating colostomy-related morbidity in children following stoma formation and closure in a tertiary hospital, Abha, Saudi Arabia: a retrospective cohort study 2024
    Hashim Ali Alghamdi, Meshari Saad M Alqahtani, Hatem Mostafa Mohammed Asiri, Abdulaziz Mohammed M Abudasir, Khalid Talab Salem Alshahrani, Rahaf Ahmed Alamer, Ali Abdullah S Alshahrani, Yasir Abduallah M Alyahya, Anas Mohammed abudasir, Saeed Jarallah S A
    BMC Pediatrics.2024;[Epub]     CrossRef
  • A nutritional screening threshold for optimal outcomes after Hartmann’s reversal
    Suzanne M. Arnott, Benjamin Zollinger, Sarah Haviland, Matthew Ng, Vincent Obias
    International Journal of Colorectal Disease.2022; 37(9): 2041.     CrossRef
  • Nutritional and Educational Intervention to Recover a Healthy Eating Pattern Reducing Clinical Ileostomy-Related Complications
    Antonio Fernández-Gálvez, Sebastián Rivera, María del Carmen Durán Ventura, Rubén Morilla Romero de la Osa
    Nutrients.2022; 14(16): 3431.     CrossRef
  • Classification of the complications of the loop-ileostomy closure procedure according to the Clavien-Dindo grading system
    Okan M. AKTURK, Mikail CAKIR
    Chirurgia.2021;[Epub]     CrossRef
  • Descriptive Study of Pediatric Patients with Ileum Stoma at Inpatient Installation of Dr. Soetomo General Hospital Surabaya
    Farihazqa Hafez Mikala, Alpha Fardah Athiyyah, I Gusti Bagus Adria Hariastawa, I Gusti Made Reza Gunadi Ranuh
    JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga.2021; 12(1): 1.     CrossRef
  • Pre- and Post-Operative Nutrition Assessment in Patients with Colon Cancer Undergoing Ileostomy
    Georgios Vasilopoulos, Panagiota Makrigianni, Maria Polikandrioti, Ilias Tsiampouris, Dimitrios Karayiannis, Nikoletta Margari, Lamprini Avramopoulou, Georgia Toulia, Georgia Fasoi
    International Journal of Environmental Research and Public Health.2020; 17(17): 6124.     CrossRef
  • Effective methods to decrease surgical site infections in pediatric gastrointestinal surgery
    Andrew B. Nordin, Stephen P. Sales, Gail E. Besner, Marc A. Levitt, Richard J. Wood, Brian D. Kenney
    Journal of Pediatric Surgery.2018; 53(1): 52.     CrossRef
  • Preoperative Body Mass Index and Postoperative Complications After Pelvic Exenteration in Recurrent or Locally Advanced Rectal Cancer Patients
    Moo-Jun Baek
    Annals of Coloproctology.2014; 30(2): 60.     CrossRef

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP